secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001437749-25-017237
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q1 rev $1.6M, net loss widens; Nasdaq bid price deficiency notice
-------------------------------------------------------------------------

- Q1 2025 revenue $1.6M (-25% YoY); net loss $736k vs $510k; EPS ($0.16) vs ($0.32).
- Cash and equivalents $3.1M at Mar 31, up from $438k at Dec 31, on warrant exercises.
- Nasdaq notice on May 9: bid price below $1.00 for 30 days; compliance deadline Nov 5, 2025.
- Gross margin 82.6%; SG&A down 23% YoY to $1.37M; operating expenses reduced 18%.
- New partnerships: Arrow ECS Iberia, California Ed Tech JPA; deployed PortalGuard for National Bank of Egypt (30k users).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925017237/0001437749-25-017237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774925017237/bkyi20250512_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-017237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer